Loading...
For the first time in several years, the Interscience Conference on Antimicrobial Agents and Chemotherapy and the Infectious Diseases Society of America hosted a joint annual meeting, attracting some 13,000 infectious disease (ID) specialists to Washington, DC. As expected, the meeting provided myriad opportunities to catch up on general ID medicine, but it also included some important presentations specifically on HIV.
Gilead Sciences; GlaxoSmithKline/ViiV; Merck; Shionogi
NIH; Gilead Sciences; ViiV
UpToDate; Clinical Infectious Diseases
For nearly 2 decades, we have been debating when to start antiretroviral therapy (ART) in asymptom…